SCHEMBL5456024

SCHEMBL5456024

COc1ccc2c(c1)nc(N)n2C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
POLB P06746 2/20 0.57
HTT P42858 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.55
ACSS2 Q9NR19 1/20 0.52
FGFR1 P11362 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
CACNA1D Q01668 1/20 0.47
RAD51 Q06609 1/20 0.47
MAPT P10636 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
RPS6KA5 O75582 1/20 0.45
KDM4E B2RXH2 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
NCF1 P14598 1/20 0.45
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456431 0.86 CYP1A2 (0.50) ALDH1A1POLBHTTSMN1; SMN2ACSS2
SCHEMBL5470441 0.82 MAPT (0.70) ALDH1A1POLBHTTACSS2MAPT
SCHEMBL5458735 0.81 NPC1 (0.49) ALDH1A1POLBHTTSMN1; SMN2ACSS2
SCHEMBL14344232 0.81 MAPT (0.69) ALDH1A1SMN1; SMN2ACSS2TDP1MAPT
SCHEMBL2361751 0.80 ALDH1A1 (0.55) ALDH1A1POLBHTTSMN1; SMN2FGFR1
SCHEMBL25443596 0.79 ALDH1A1 (0.55) ALDH1A1POLBHTTSMN1; SMN2ACSS2
SCHEMBL3965377 0.79 ALDH1A1 (0.55) ALDH1A1POLBHTTSMN1; SMN2ACSS2
SCHEMBL1104364 0.79 ALDH1A1 (0.55) ALDH1A1POLBHTTSMN1; SMN2ACSS2
Hydrochloric Acid SCHEMBL7236753 0.79 CCR1 (0.46) ALDH1A1POLBHTTSMN1; SMN2ACSS2
SCHEMBL28370090 0.79 CLK4 (0.41) ALDH1A1POLBHTTSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 ALDH1A1 39/4885POLB 2088/4885HTT 4363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.